Clinical Trial Update: Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 double-blind, randomized, placebo-controlled trial of etanercept for psoriatic arthritis and psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Amgen | Conditions: Psoriatic Arthritis, Psoriasis | Phase 3 | Status: COMPLETED